Geisinger Health System rheumatologists have created a new care model for rheumatoid arthritis patients that has produced significant improvement in quality of care and reduced cost through 22 months of follow-up.
Attribution, Integration, Measurement, Finances, and Reporting of Therapies (AIM FARTHER) is the new value-based, population-care model designed and tested on 2,378 RA patients cared for by 17 Geisinger rheumatologists. The rheumatologists launched AIM FARTHER in August 2012 and reported that cost savings tallied from de-escalating use of costly biologic drugs came to $720,000 for 2013. They project a savings estimate of $1.2 million for 2014.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access